Improving efficacy of cancer immunotherapy through targeting of macrophages
T cell-based immunotherapies have revolutionized the treatment against cancer. But complete and long-lasting efficacy is only observed in a fraction of the patient population. One of the suspected causes is the inability of cytotoxic T cells, endowed with tumor killing ability, to reach their malign...
Saved in:
Main Authors: | Elisa Peranzoni (Author), Emmanuel Donnadieu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer
by: Mei-Ye Li, et al.
Published: (2024) -
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
by: Alexandre M. M. Dias, et al.
Published: (2022) -
Editorial: Targeted Immunotherapy for Cancer
by: Williams V. Williams
Published: (2022) -
Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021) -
Targeting iNOS to increase efficacy of immunotherapies
by: Suhendan Ekmekcioglu, et al.
Published: (2017)